Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Клинические практические рекомендации Общества инфекционных болезней Америки по лечению инфекций, вызванных метициллин-резистентным Staphylococcus aureus, у взрослых и детей
Sara E. Cosgrove, Donald P. Levine, Adolf W. Karchmer, Barbara E. Murray, Sheldon L. Kaplan, David A. Talan, Scott K. Fridkin, Henry F. Chambers, Catherine Liu, Arnold S. Bayer, Robert S. Daum, Rachel Gorwitz, Michael J. Rybak
2011-01-06
SCID:  54.1/pqa6fckw Discuss with AI
MRSA infectionsbacteremia and endocarditismethicillin-resistant Staphylococcus aureusskin and soft tissue infectionsvancomycin dosing and monitoring
Abstract (AI)
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Key Findings
1
Recommendations cover vancomycin dosing and therapeutic monitoring for MRSA infections.
2
The IDSA Expert Panel developed evidence-based guidelines for treating methicillin-resistant Staphylococcus aureus infections in both adults and children.
3
The guidelines address management of MRSA skin and soft tissue infections, bacteremia, endocarditis, pneumonia, bone and joint infections, and central nervous system infections.
4
The guidelines provide management strategies for MRSA strains with reduced vancomycin susceptibility and for cases of vancomycin treatment failure.
Research Object

Clinical practice guidelines for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in adults and children

Research Subject

Clinical management and treatment recommendations across MRSA-associated syndromes, including antimicrobial dosing, reduced vancomycin susceptibility, and treatment failure

Publication Details
Publication Date
2011-01-06
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Sara E. Cosgrove
Donald P. Levine
Adolf W. Karchmer
Barbara E. Murray
Sheldon L. Kaplan
David A. Talan
Scott K. Fridkin
Henry F. Chambers
Catherine Liu
Arnold S. Bayer
Robert S. Daum
Rachel Gorwitz
Michael J. Rybak
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%